Get the Stockscreener App
118.57
5.36%
-6.72
Twist Bioscience Corp stock is traded at $118.57, with a volume of 1.14M.
It is down -5.36% in the last 24 hours and up +28.14% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$125.29
Open:
$124.09
24h Volume:
1.14M
Relative Volume:
0.65
Market Cap:
$7.44B
Revenue:
$409.48M
Net Income/Loss:
$-81.28M
P/E Ratio:
-89.24
EPS:
-1.3286
Net Cash Flow:
$-95.14M
1W Performance:
+2.51%
1M Performance:
+28.14%
6M Performance:
+141.44%
1Y Performance:
+311.13%
1-Day Range:
$118.44
$124.71
1-Week Range:
$113.18
$126.40
52-Week Range:
$23.30
$126.40
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
118.57 | 7.85B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience CEO Emily Leproust Executes Sale of 19,952 Shares via 10b5-1 Plan - Kalkine Media
Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Director Katryn Blake Executes Sell-to-Cover of 2,240 Shares for RSU Tax Obligations - Kalkine Media
Twist Bioscience (TWST) director sells 2,240 shares to cover RSU tax - Stock Titan
Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake - Stock Titan
Twist Bioscience (NASDAQ:TWST) Trading Down 4.3%Here's What Happened - MarketBeat
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
Twist Bioscience (TWST): EdgePoint discloses 4.21% beneficial stake in amended 13G - Stock Titan
Artisan Partners group (TWST) discloses 4.8M-share position in Twist Bioscience - Stock Titan
Twist Bioscience stock hits 52-week high at 126.22 USD - Investing.com
Twist Bioscience CEO Emily Leproust Executes Stock Option Exercise and Sells 113,318 Shares Under 10b5-1 Plan - Kalkine Media
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells $14,182,880.88 in Stock - MarketBeat
Twist Bioscience (TWST) insider Leproust plans resale after option exercise - Stock Titan
E. Ohman J or Asset Management AB Makes New Investment in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (TWST) stake of 3.5% reported by William Blair Investment Management - Stock Titan
Wrapped Twist Bioscience Tokenized Stock (xStock) price today, wTWSTx to USD live price, marketcap and chart - CoinMarketCap
Twist Bioscience Director Robert Chess Reports Stock Option Exercise and Sale in SEC Form 4 Filing - Kalkine Media
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech) - finance.yahoo.com
A Look at Twist Bioscience Corp (TWST) After 8.0% Gain -- GF Val - GuruFocus
TWST shareholder (NASDAQ: TWST) files to sell 113,318 common shares - Stock Titan
Twist Bioscience TWST Jumps As Guidance, Targets And Cash Raise Align - StocksToTrade
Twist Bioscience (NASDAQ:TWST) Reaches New 1-Year HighHere's What Happened - MarketBeat
California State Teachers Retirement System Boosts Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (TWST) Is Up 26.3% After Capital Raise And Guidance Hike Amid Legal Settlement TalksHas The Bull Case Changed? - Yahoo Finance
Twist Bioscience (TWST) Institutional Ownership 2026 $TWST - MarketBeat
Is Twist Bioscience Corp (TWST) Overvalued After 6.0% Rally? GF - GuruFocus
Revenue Growth Reinforces Twist Bioscience Corp.’s (TWST) Technology Leadership - Yahoo Finance
FMR LLC discloses 7.6% Twist Bioscience (TWST) holding in new ownership filing - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation (NASDAQ:TWST) Price Target To US$104 - simplywall.st
Twist Bioscience Corporation (NASDAQ:TWST) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Twist Bioscience Corp (TWST) Shares Surge 15.7% -- What GF Score of 69 Tells Investors - GuruFocus
Twist Bioscience Nets ~$327 Million From $96-Per-Share Underwritten Stock Offering - TradingView
Twist Bioscience (NASDAQ: TWST) COO sells 2,888 shares for tax withholding - Stock Titan
Twist Bioscience (TWST) SVP sells 1,070 shares in tax sell-to-cover transaction - Stock Titan
Twist Bioscience (TWST) Jumps As Revenue, Targets And Offering Reshape The Trade - StocksToTrade
Dennis H. Cho plans TWST (TWST) stock sale of 14,205 shares under Form 144 - Stock Titan
Twist Bioscience (NASDAQ:TWST) Trading 10.3% Higher on Analyst Upgrade - MarketBeat
Earnings call transcript: Twist Bioscience Q3 2026 revenue beats, shares fall premarket - Investing.com Nigeria
Moody National Bank Trust Division Purchases Shares of 20,316 Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Prices Upsized Public Offering of 3.125 Million Shares - Intellectia AI
Twist Bioscience prices $300M stock offering at $96 per share - Investing.com
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock - Business Wire
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock - Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Finviz
Twist Bioscience (NASDAQ:TWST) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Twist Bioscience Corp stock hits 52-week high at 106.58 USD - Investing.com
Twist Bioscience Corporation Q3 2026 Earnings Call Summary - finance.yahoo.com
Twist Bioscience (NASDAQ:TWST) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Is Twist Bioscience Corp (TWST) Overvalued Despite Q3 Revenue Su - GuruFocus
First Trust Advisors LP Acquires New Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience posts strong 23% revenue growt... - Pluang
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):